Hyoun-Wook Kim*, Cheolmin Shin*, Seung-Hoon Lee, Changsu Han. Clin Psychopharmacol Neurosci 2021;19:104-11. https://doi.org/10.9758/cpn.2021.19.1.104

Junhyung Kim, Hyun-Ghang Jeong, Moon‑Soo Lee, Seung-Hoon Lee, Sang-Won Jeon, Changsu Han. Clin Psychopharmacol Neurosci 2023;21:732-41. https://doi.org/10.9758/cpn.23.1049

Cheolmin Shin, Sang Won Jeon, Seung-Hoon Lee, Chi-Un Pae, Narei Hong, Hyun Kook Lim, Ashwin A. Patkar, Prakash S. Masand, Hyonggin An, Changsu Han. Clin Psychopharmacol Neurosci 2023;21:135-46. https://doi.org/10.9758/cpn.2023.21.1.135

Obstructive sleep apnea (OSA) is a common disorder characterized by upper airway obstruction during sleep. To reduce the morbidity of OSA, sleep specialists have explored various methods of managing the condition, including manifold positive airway pressure (PAP) techniques and surgical procedures. Nasal obstruction can cause significant discomfort during sleep, and it is likely that improving nasal obstruction would enhance the quality of life and PAP compliance of OSA patients. Many reliable studies have offered evidence to support this assumption. However, few comprehensive guidelines for managing OSA through nasal surgery encompass all this evidence. In order to address this gap, the Korean Society of Otorhinolaryngology-Head and Neck Surgery (KORL-HNS) and the Korean Society of Sleep and Breathing designated a guideline development group (GDG) to develop recommendations for nasal surgery in OSA patients. Several databases, including OVID Medline, Embase, the Cochrane Library, and KoreaMed, were searched to identify all relevant papers using a predefined search strategy. The types of nasal surgery included septoplasty, turbinate surgery, nasal valve surgery, septorhinoplasty, and endoscopic sinus surgery. When insufficient evidence was found, the GDG sought expert opinions and attempted to fill the evidence gap. Evidence-based recommendations for practice were ranked according to the American College of Physicians’ grading system. The GDG developed 10 key action statements with supporting text to support them. Three statements are ranked as strong recommendations, three are only recommendations, and four can be considered options. The GDG hopes that this clinical practice guideline will help physicians make optimal decisions when caring for OSA patients. Conversely, the statements in this guideline are not intended to limit or restrict physicians’ care based on their experience and assessment of individual patients.

Seung-Hoon Lee, Cheolmin Shin, Young-Hoon Ko, Moon-Soo Lee, Moon Ho Park, Chi-Un Pae, Ho-Kyoung Yoon, Changsu Han. Clin Psychopharmacol Neurosci 2023;21:147-61. https://doi.org/10.9758/cpn.2023.21.1.147